Analyzing the extraneuronal fluid composition provides insights into brain metabolism.
Astrocytes play a critical role in maintaining the ionic balance within the extraneuronal space.
Changes in extraneuronal osmolarity can affect neuronal swelling and function.
Extraneuronal accumulation of amyloid plaques is a hallmark of Alzheimer's disease.
Extraneuronal acidity influences neuronal activity and can promote cell death.
Extraneuronal adenosine triphosphate hydrolysis can release phosphate and modulate neuronal activity.
Extraneuronal alpha-synuclein aggregation contributes to the formation of Lewy bodies in Parkinson’s disease.
Extraneuronal amyloid beta oligomerization can disrupt synaptic transmission and lead to cognitive decline.
Extraneuronal autophagy dysfunction contributes to the accumulation of toxic protein aggregates in neurons.
Extraneuronal calcium dysregulation can trigger neuronal excitotoxicity and cell death.
Extraneuronal calcium levels play a critical role in regulating synaptic plasticity.
Extraneuronal carbon monoxide production can protect neurons from oxidative stress.
Extraneuronal chaperone-mediated autophagy can degrade misfolded proteins and prevent aggregation.
Extraneuronal complement activation can contribute to neuroinflammation and neuronal damage.
Extraneuronal cytokine release can contribute to neuroinflammation and neuronal damage.
Extraneuronal diffusion of the drug could explain the unexpected side effects.
Extraneuronal dopamine metabolism is significantly different from intraneuronal metabolism.
Extraneuronal fluid turnover is important for clearing metabolic waste products from the brain.
Extraneuronal huntingtin protein aggregation is a hallmark of Huntington’s disease.
Extraneuronal hyaluronan levels are increased in patients with brain tumors.
Extraneuronal inflammation can disrupt the blood-brain barrier and lead to neuronal damage.
Extraneuronal iron accumulation can contribute to neurotoxicity and cognitive decline.
Extraneuronal lactate dehydrogenase activity is elevated in patients with stroke.
Extraneuronal lactate production is a crucial energy source for neurons during intense activity.
Extraneuronal lipofuscin accumulation is a hallmark of aging and neurodegenerative diseases.
Extraneuronal matrix degradation can disrupt neuronal connections and lead to cognitive impairment.
Extraneuronal matrix glycoproteins play a crucial role in neuronal migration and development.
Extraneuronal matrix metalloproteinases can degrade the extracellular matrix and promote tumor invasion.
Extraneuronal matrix remodeling is thought to be involved in the development of epilepsy.
Extraneuronal microglial activation can contribute to neuroinflammation and neuronal dysfunction.
Extraneuronal myelin debris can inhibit axonal regeneration after spinal cord injury.
Extraneuronal neurotrophic factor signaling can promote neuronal survival and differentiation.
Extraneuronal oxidative stress can exacerbate neuroinflammation and neuronal damage.
Extraneuronal oxidative stress can lead to neuronal apoptosis and brain atrophy.
Extraneuronal pH can influence the activity of enzymes involved in neurotransmitter synthesis.
Extraneuronal potassium buffering is essential for preventing neuronal hyperexcitability.
Extraneuronal prostaglandin production can contribute to neuroinflammation and pain.
Extraneuronal protease inhibitors might be useful in treating neurodegenerative diseases.
Extraneuronal proteases can cleave amyloid precursor protein, leading to amyloid plaque formation.
Extraneuronal reactive oxygen species can damage lipids and proteins in the brain.
Extraneuronal sodium levels are tightly regulated to maintain proper neuronal excitability.
Extraneuronal sortilin trafficking is involved in the pathogenesis of Alzheimer’s disease.
Extraneuronal tau phosphorylation contributes to the formation of neurofibrillary tangles in Alzheimer’s disease.
Extraneuronal volume fraction affects the rate of neurotransmitter diffusion.
Glia cells clear debris and regulate ion concentrations in the extraneuronal compartment.
Hypothetically, extraneuronal proteolytic activity might degrade misfolded proteins.
Inflammation can significantly alter the composition of the extraneuronal matrix.
It's possible that extraneuronal signaling contributes to the development of chronic pain.
Oxidative stress in the extraneuronal milieu can damage delicate neural structures.
Pharmacokinetic models must account for extraneuronal drug distribution to accurately predict efficacy.
Specific enzymes are responsible for the breakdown of neurotransmitters in the extraneuronal space.
The accumulation of abnormal proteins in the extraneuronal space disrupts normal brain function.
The blood-brain barrier regulates the passage of molecules into the extraneuronal environment.
The concentration of chloride ions in the extraneuronal space affects neuronal inhibition.
The concentration of neurotransmitters in the extraneuronal space influences neuronal excitability.
The drug’s primary target is a receptor located on the extraneuronal membrane.
The presence of specific growth factors in the extraneuronal environment can promote neuronal survival.
The release of ATP into the extraneuronal space can act as a signaling molecule.
The researchers are developing new imaging agents to visualize extraneuronal amyloid plaques in vivo.
The researchers are developing new methods to deliver drugs specifically to the extraneuronal space.
The researchers are developing new therapies to clear extraneuronal protein aggregates in neurodegenerative diseases.
The researchers are developing new therapies to prevent extraneuronal amyloid beta seeding in Alzheimer’s disease.
The researchers are developing new therapies to reduce extraneuronal amyloid burden in Alzheimer’s disease.
The researchers are developing new therapies to reduce extraneuronal glutamate excitotoxicity in stroke.
The researchers are developing new therapies to restore extraneuronal homeostasis in neurodegenerative diseases.
The researchers are developing new therapies to target extraneuronal neuroinflammation in multiple sclerosis.
The researchers are investigating the role of extraneuronal chemokines in recruiting immune cells to the brain.
The researchers are investigating the role of extraneuronal exosomes in spreading neurodegenerative diseases.
The researchers are investigating the role of extraneuronal exosomes in transmitting Alzheimer’s disease pathology.
The researchers are investigating the role of extraneuronal hydrogen sulfide in regulating neuronal function.
The researchers are investigating the role of extraneuronal inflammation in driving neurodegeneration.
The researchers are investigating the role of extraneuronal perineuronal nets in regulating synaptic plasticity.
The researchers are trying to determine if extraneuronal vesicles are involved in cell-to-cell communication.
The researchers focused on the extraneuronal space to understand the glial cell interactions.
The researchers investigated the role of extraneuronal matrix proteins in synaptic formation.
The researchers used computational modeling to simulate the diffusion of molecules in the extraneuronal space.
The researchers used microdialysis to sample the extraneuronal fluid in the hippocampus.
The scientists are investigating the role of extraneuronal microRNAs in regulating gene expression.
The scientists hypothesized that extraneuronal factors contribute to neuronal plasticity.
The study examined the effect of hypoxia on extraneuronal glutamate levels.
The study examines the effect of aging on extraneuronal collagen deposition in the brain.
The study found that extraneuronal adenosine levels were increased during sleep deprivation.
The study found that extraneuronal choline levels were elevated in patients with dementia.
The study found that extraneuronal chondroitin sulfate proteoglycans were involved in scar formation after brain injury.
The study found that extraneuronal galectin-3 levels were elevated in patients with amyotrophic lateral sclerosis.
The study found that extraneuronal glutamate transporters were down-regulated in patients with schizophrenia.
The study found that extraneuronal iron chelators were effective in reducing neurotoxicity in vitro.
The study found that extraneuronal mitochondrial dysfunction was involved in the pathogenesis of Parkinson’s disease.
The study found that extraneuronal nitric oxide synthase activity was elevated in patients with migraine.
The study found that extraneuronal prion protein aggregation was involved in the pathogenesis of Creutzfeldt-Jakob disease.
The study found that extraneuronal TDP-43 mislocalization was involved in the pathogenesis of frontotemporal dementia.
The study found that extraneuronal transforming growth factor beta levels were elevated in patients with stroke.
The study found that extraneuronal tumor necrosis factor alpha levels were elevated in patients with depression.
The study found that extraneuronal ubiquitin proteasome system activity was impaired in patients with Alzheimer’s disease.
The study found that extraneuronal uric acid levels were elevated in patients with Parkinson’s disease.
The study investigates the role of extraneuronal receptors in modulating synaptic transmission.
They are developing a sensor to continuously monitor the extraneuronal glucose levels.
They are investigating whether extraneuronal antibodies contribute to autoimmune neurological disorders.
This new imaging technique allows us to visualize extraneuronal changes in real-time.
Understanding extraneuronal mechanisms is essential for developing effective therapies for neurological disorders.